LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has...